Yi-Gang Wang

The future of cancer therapy? Integrating oncolytic adenoviruses with epigetic modulation.

Therapeutic resistance remains a defining limitation in the management of advanced solid tumors, where conventional modalities including chemotherapy, radiotherapy, and immune checkpoint blockade often fail to achieve durable responses. Oncolytic adenoviruses (OAds) have emerged as tumor-selective and immunogenic platf...